about
Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in ratsPiglet model of chronic pulmonary hypertension.The beneficial effect of suramin on monocrotaline-induced pulmonary hypertension in ratsProtein changes contributing to right ventricular cardiomyocyte diastolic dysfunction in pulmonary arterial hypertensionInflammation in pulmonary arterial hypertension.Increased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension.Dexamethasone induces apoptosis in pulmonary arterial smooth muscle cells.Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.Current insights on the pathogenesis of pulmonary arterial hypertension.Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension.Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension.A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents.Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension.Relevant issues in the pathology and pathobiology of pulmonary hypertension.Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension.Evidence for the involvement of type I interferon in pulmonary arterial hypertension.Pulmonary veno-occlusive disease: recent progress and current challenges.Pulmonary veno-occlusive disease: the bête noire of pulmonary hypertension in connective tissue diseases?Pulmonary veno-occlusive disease: advances in clinical management and treatments.Pathology and pathobiology of pulmonary hypertension.Pulmonary hypertension: pathology.Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay.Chemotherapy-induced pulmonary hypertension: role of alkylating agents.T-type Ca2+ channels elicit pro-proliferative and anti-apoptotic responses through impaired PP2A/Akt1 signaling in PASMCs from patients with pulmonary arterial hypertension.The Pathobiology of Chronic Thromboembolic Pulmonary Hypertension.Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.The pathophysiology of chronic thromboembolic pulmonary hypertension.BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension.Ventilation/perfusion lung scan in pulmonary veno-occlusive disease.[A case of lung infection imported from the United-States].Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease.Lymphoproliferative Disorders after Lung Transplantation: Clinicopathological Characterization of 16 Cases with Identification of Very-Late-Onset Forms.Crystalline ultrastructures, inflammatory elements, and neoangiogenesis are present in inconspicuous aortic valve tissue.[In vitro effects of diclofenac and selective cyclooxygenase-2 inhibitors on prostaglandin release from inflamed bursa subacromialis tissue in patients with subacromial syndrome].A diffuse lung emphysema, severe pulmonary hypertension and lack of airflow limitation.Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndrome.Association of pulmonary aspergilloma and allergic bronchopulmonary aspergillosis.Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet.[Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis].
P50
Q33329056-C9A0D9D6-D03F-41E0-8FF9-9E94F041C97AQ33786092-B3D1FBA0-679C-4812-B696-089BF70CEAD1Q33806241-ED6B2DC8-71E5-44AE-BD4B-87F42D02FF64Q35021663-C3B0355C-46B4-4304-9BE7-9D58845A6D6FQ35021804-184CD9FF-4670-473B-9AA9-ED6ADB17E5CFQ35210445-5D75CFA7-2AF7-4CA8-A04E-4F063F475C7EQ35289907-585259D3-D98A-4FA1-9C3C-5C063A6E14C1Q35779717-7AFB9E54-35EC-44B5-82BA-3A795A921D3CQ36079101-18DE371F-7809-43A8-B1FF-CE48EDDD306AQ36240249-F9A21033-E23E-42E1-9213-26710796D6FAQ37209074-D70ED961-DFAD-474D-BCB9-DBFE13AC9096Q37215728-16FAD2B1-A27C-4544-9F41-0AAE2A57627BQ37410202-6CB46D3D-77F6-4899-980E-E32F56646488Q37536677-5317E857-62E7-42EF-B358-552552B37973Q37673917-AB74C77B-B59D-4B0C-81FD-E06E2087BF0AQ37698113-B449A8AE-8223-485E-AB19-C3169F109729Q37735087-A658E9E2-5006-464C-AE2F-2C91E817C064Q37747995-6031B600-9411-438E-8E13-459D9C638C58Q37826548-42E1AEB6-2BCA-42AF-8ABB-FC3FFE15F582Q37867672-DA14D707-4170-4008-947A-94EAA7072AA7Q38137781-7678A9AC-9CF0-4C14-9F11-3580D4C4A180Q38149023-2B635BB3-DD4C-43F5-B093-14C5735C5D6CQ38198974-B575666E-1D2C-4E39-8109-60905317C0D2Q38286586-728F9454-D9A7-4863-A3B4-59C96717D195Q38706299-778E3C5A-BD20-4226-9E47-C217D78C6F51Q38939738-D3CCDC28-850C-4AA9-A286-946F1663C04AQ39021300-F67F0FDE-734A-44B1-85D5-434A1322BAB0Q39207429-B1F69E8E-6DC7-452E-BAA6-96B83CADC758Q39218460-C7526CD0-5279-4608-9F11-BE62C1454B0BQ39686394-1E5A9882-8551-4EE6-9BC1-7A38FF53F437Q40288033-FFF6E635-255C-40EE-8021-1EB836275061Q40351526-42C1B079-9168-46B0-A566-54D664120560Q40387149-62C4B165-B839-442A-8FAC-1A27409F2447Q41894232-82053AAA-207D-4CCD-8441-045764329205Q42165802-69AAF004-B05F-43A0-8D29-376E61B36202Q42235236-FE698684-3A33-40F8-B2A0-E31EFD428BD7Q42261957-3E9A432B-96EB-42F6-8DB9-C411B7693ADDQ42789653-9ECF5F22-89CC-4F79-9453-2B6BE2598492Q43114841-24028CAC-96BF-4480-9950-34B8EFC0DFDEQ43242208-2F2A0BB9-D9D2-4FCD-BFF4-AEF503CD814C
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Peter Dorfmuller
@ast
Peter Dorfmuller
@en
Peter Dorfmuller
@es
Peter Dorfmuller
@nl
Peter Dorfmuller
@sl
type
label
Peter Dorfmuller
@ast
Peter Dorfmuller
@en
Peter Dorfmuller
@es
Peter Dorfmuller
@nl
Peter Dorfmuller
@sl
altLabel
Peter Dorfmuller
@en
prefLabel
Peter Dorfmuller
@ast
Peter Dorfmuller
@en
Peter Dorfmuller
@es
Peter Dorfmuller
@nl
Peter Dorfmuller
@sl
P214
P106
P21
P214
P31
P496
0000-0003-2499-6829
P735
P7859
viaf-263998634